Surface AtlasMucinous colon cancer

TACSTD2

Tumor-associated calcium signal transducer 2. UniProt annotates extracellular residues 27–274.

Published binding interface

Structure 9PI9 records TACSTD2 in contact with sacituzumab Fab. Select the contact residues to inspect this interface.

Open this view

RNA expression by cell type

Percentage of cells with detected TACSTD2 RNA in the public colon adenocarcinoma cell groups.

Tumor cells19.4%
Endothelial cells7.4%
Dendritic cells4.6%
Macrophages (group B)3.0%
Fibroblasts3.0%
Macrophages (group A)2.2%
Regulatory T cells1.3%
Adipocytes0.6%
CD4 T cells0.5%
Granulocytes0.5%
Natural killer cells0.5%
CD8 T cells0.5%
B cells0.1%
RNA detection · Cancer Surfaceome Atlas, Table S6, row 253. Source study · Measurements (JSON)

Inspect the molecular structure

Published reference structure

TROP2 with sacituzumab

Deposited structure 9PI9. TROP2 dimer bound by sacituzumab Fab.
Deposited structure 9PI9. TROP2 dimer bound by sacituzumab Fab.

PDB entry
9PI9
Target ID
T-ENSG00000184292
  • sacituzumab Fab heavy chain · chains A, C (ribbon)
  • sacituzumab Fab light chain · chains B, D (ribbon)
  • TROP2 dimer · chains E, F (ribbon)

Sequence & binding sites

Choose a protein region, search amino-acid letters, or inspect a recorded binding site.

Loading sequence…

Open the sequence explorer
Sequence annotations and source records

Canonical sequence and topology

Target ID
T-ENSG00000184292
UniProt accession
P09758
Sequence state
available
Canonical sequence
Yes
Length in amino acids
323
Sequence SHA-256
f337b2b4d3670cc9da5ce68671c1e4c1d5cbd6d6c9d04d0f76cffca42e43a1da
View and select the full canonical sequence
Sequence positions 1–323

Gray shows the full canonical sequence. Colored spans mark the listed intervals.

Signal peptide
1–26
1–26
Membrane-spanning segments
275–297: Helical
275–297 (Helical)
Source-annotated domains
27–274: Extracellular298–323: Cytoplasmic
27–274 (Extracellular); 298–323 (Cytoplasmic)
Source-annotated extracellular intervals
27–274
27–274

UniProt annotates the following extracellular intervals.

One-based positions include both interval endpoints.
StartEndLengthSequence and source
27274248
Sequence and source
Basis
reviewed-uniprot-topological-domain
Evidence class
source-annotated-topology
Sequence SHA-256
48435a564c770c931554dab25ce15095db7b14f5879eb7a37db90d5a6b1c71a2
Sequence and topology sources
Source role
canonical-sequence
Source
alphafold-db-canonical-uniprot-field
Extracted field
uniprotSequence
Source row accession
Not recorded

Download source snapshot

Open sequence source
Source role
reviewed-topology
Source
UniProt reviewed human surface-field snapshot
Extracted field
Not recorded
Source row accession
P09758

Download source snapshot (gzip)

subcellular_location
SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
transmembrane
TRANSMEM 275..297; /note="Helical"; /evidence="ECO:0000255"
topological_domain
TOPO_DOM 27..274; /note="Extracellular"; /evidence="ECO:0000255"; TOPO_DOM 298..323; /note="Cytoplasmic"; /evidence="ECO:0000255"
signal_peptide
SIGNAL 1..26; /evidence="ECO:0000255"
lipidation
Not recorded

Download all canonical target sequences (FASTA)

Protein identity and location

Protein
Tumor-associated calcium signal transducer 2
Protein location
Transmembrane protein
Canonical sequence
P09758 · 323 amino acids
Extracellular region
UniProt annotates extracellular residues 27–274.
More structures and generated models

Expression in normal tissues

RNA specificity
Tissue enhanced
RNA distribution
Detected in many
RNA tissue-specific nTPM
esophagus: 1,245.4; salivary gland: 585.3; skin 1: 554.9
Protein specificity
Tissue enhanced
Protein distribution
Detected in many
Immunohistochemistry reliability
Enhanced
Immunofluorescence reliability
Supported
Protein tissue-specific intensity
lung: 22,139,708.2; salivary gland: 23,989,590.1
Tissue cell-type enrichment
Liver - Cholangiocytes, Pancreas - Ductal cells, Skin - Keratinocyte (other)
Subcellular location
Plasma membrane

Structures

Sources and downloads

TACSTD2 · ENSG00000184292 · P09758

Search the report